Trump’s Drug-Price EO Should Have Happened Decades Ago

Scott McKay, The American Spectator

We are being grossly overcharged for pharmaceuticals compared to the rest of the world.

Cramming down those prices and resetting the global pharmaceutical market, while at the same time instituting some real reforms which de-cartelize that market, is an idea whose time should have come a long time ago. At some point, we could use a conversation about how big the drug market ought to be in the first place, because this is the most medicated society in the history of the world, and we can’t claim to be healthier for it.